Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.
Santoro C, Servedio M, Diana MC, Russo I, Arkhangelskaya E, Piccolo G, Santangelo A, Mastronuzzi A, Cacchione A, Hachem ME, Russo C, Cirillo M, Cecconi I, Grasso A, Loiotine M, Santoro N, Resta M, De Meco C, Soddu C, Spreafico E, Rossi B, Fossati C, Leoni C, Perrotta S, Perillo T.
Santoro C, et al. Among authors: spreafico e.
J Neurooncol. 2025 Dec;175(3):1027-1037. doi: 10.1007/s11060-025-05197-5. Epub 2025 Aug 13.
J Neurooncol. 2025.
PMID: 40802118
Free PMC article.